Durvalumab Consolidation Should Be the Standard Therapy in Stage III EGFR-Mutant NSCLC After Chemoradiation.
作者信息
Morgensztern Daniel, Govindan Ramaswamy
机构信息
Division of Medical Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Division of Medical Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
出版信息
J Thorac Oncol. 2021 Dec;16(12):1999-2001. doi: 10.1016/j.jtho.2021.07.034.
PMID:34809804
Abstract
摘要
Zotero 插件